Dietary composition alters gentamicin-induced nephrotoxicity in rats

Paquette, M.; Plante, Isabelle; Labrecque, Gaston; Beauchamp, Denis; Thibault, Louise

doi:10.1016/s0031-9384(02)00848-x

Cited by 4 publications

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have demonstrated that time of administration may affect gentamicin-, [22][23][24][25][26] tobramycin-, [27][28][29] and isepamicin- 30,31 induced toxicity in rats. 32,33 Nephrotoxicity, evaluated by the excretion of renal enzymes (N-acetyl-β-Dglucosaminidase and β-galactosidase), cortical and tubular cell lesions, blood urea nitrogen and serum creatinine level, and creatinine clearance, was maximal when the aminoglycoside was injected in the resting (day) compared to activity (night) phase in rats.…”

Section: Chronotherapy: Avoiding Unwanted Side Effectsmentioning

confidence: 99%

“…32,33 Nephrotoxicity, evaluated by the excretion of renal enzymes (N-acetyl-β-Dglucosaminidase and β-galactosidase), cortical and tubular cell lesions, blood urea nitrogen and serum creatinine level, and creatinine clearance, was maximal when the aminoglycoside was injected in the resting (day) compared to activity (night) phase in rats. [22][23][24][25][26][27][28][29][30][31] This temporal variation was modified by the feeding time, renal toxicity being maximal when the drug was injected during the fasting period. [23][24][25] Similar daily differences in aminoglycoside toxicity have been reported in human patients.…”

Section: Chronotherapy: Avoiding Unwanted Side Effectsmentioning

confidence: 99%

See 1 more Smart Citation

The molecular clock: a focus on chronopharmacological strategies for a possible control of aminoglycoside renal toxicity

Rebuelto¹

2012

CPT

View full text Add to dashboard Cite

Chronotherapy applies biological rhythmicity in order to optimize clinical treatments, relating the dosing time of the drugs to the daily variations of their therapeutic and unwanted side effects due to the fluctuations in physiological processes involved in their pharmacokinetics and/or pharmacodynamics. The goal of chronotherapy is to administer treatments at the time of day that enhances both their effectiveness and tolerance. This review intends to (1) provide the theoretical rationale behind the use of aminoglycosides during extended interval schedule chronotherapy in clinical practice and (2) target the underlying molecular mechanisms of renal toxicity, the main unwanted side effect. Previous reports suggest that aminoglycoside therapy may benefit from a chronopharmacological approach. Temporal variations in the renal blood flow and glomerular filtration rate and several clock-dependent molecular mechanisms contributing to the daily changes in electrolyte and water urinary excretion have been reported. Daily differences in aminoglycoside toxicity and kinetic disposition have been found in laboratory animals and human patients. Nephrotoxicity and renal cortical accumulation are higher when drugs are administered during the rest phase than during the active phase. Active translocation of aminoglycosides into renal cells is mediated by the megalin/cubilin receptor complex located at the luminal epithelial cell membrane. The complex regulation of this endocytic mechanism deserves further study, in order to dilucidate the molecular bases that may be involved in chronotherapeutic strategies developed for minimizing aminoglycoside accumulation in the renal cells, and thus, increasing their tolerance.

show abstract